Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation
2019 ◽
Vol 20
(4)
◽
pp. 819
◽
2017 ◽
Vol 36
(5)
◽
pp. 1182-1194
◽
2019 ◽
Vol 29
(2)
◽
pp. 255-261
◽
Keyword(s):
2011 ◽
Vol 51
(6)
◽
pp. 1376-1392
◽
2020 ◽
Vol 89
◽
pp. 107398